SYRE

93.4704.26%
SL

Scott L. Burrows

Chief Financial Officer

Mr. Scott L. Burrows is Chief Financial Officer at Spyre Therapeutics, Inc. from September 01, 2023. He served as Chief Financial Officer and Principal Accounting Officer at Arcutis Biotherapeutics, Inc. since April 01, 2021 until August 31, 2023 and also served as it's Senior Vice President. Mr. Burrows was Vice President of Finance at Arcutis Biotherapeutics, Inc since May 2019 until April 01, 2021. Prior to joining Arcutis, he was the Head of International Investor Relations for Shire Plc in Zug, Switzerland from March 2018 to May 2019. Previously, he spent at Amgen in various finance roles of increasing responsibility, including Financial Planning & Analysis, Treasury and Investor Relations commencing in 2003. Mr. Burrows started his career as a management consultant with Arthur Andersen in Los Angeles. He received both his MBA and B. A. in Business Economics from UCLA and is a Certified Public Accountant (inactive).

Positions